Binaxnow covid-19 AG card
Ended Awarded Last action
- Contract number
- SPE2D626F34GD
- Awardee
-
Abbott Rapid DX North America LLC UEI P782RNU1NNK3 Part of Abbott Laboratories Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,608
Award facts
- Contract value 100% obligated
- $1,608.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Lake Mary, FL 32746, USA
Award details come from SAM.gov/FPDS.
About this award
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,608.08 for BinaxNOW COVID-19 antigen test cards. The contract, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, carries a fixed-price structure with economic price adjustment provisions. Funding originates from the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies for Department of Defense operations and related healthcare requirements. No set-aside designation was utilized in this award, and performance will take place in Lake Mary, Florida.
This delivery order represents a continuation of Abbott's established role as a critical supplier of diagnostic testing products to federal healthcare agencies. Abbott Rapid DX North America LLC has demonstrated sustained performance across multiple federal procurement vehicles, including blanket purchase agreements and indefinite delivery contracts with the Department of Veterans Affairs, Defense Health Agency, and Defense Logistics Agency. The company's product portfolio emphasizes point-of-care testing devices and rapid diagnostic solutions, with the BinaxNOW platform serving as a key offering for federal agencies requiring accessible COVID-19 antigen testing capabilities. The modest ceiling value reflects a routine replenishment order within Abbott's broader federal supply chain relationships that collectively support government healthcare readiness initiatives.
Quick answers
Who was awarded contract SPE2D626F34GD?
SPE2D626F34GD was awarded to Abbott Rapid DX North America LLC by Medical Supply Chain (Troop Support) on January 29, 2026.
How much is contract SPE2D626F34GD worth?
The government has obligated $1,608 on SPE2D626F34GD.
Is contract SPE2D626F34GD an order under another contract?
Yes. SPE2D626F34GD is a delivery order under SPE2DE21D0017, an indefinite delivery contract.
Was contract SPE2D626F34GD competed?
The extent of competition for SPE2D626F34GD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award